Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Profits Richest's Profile
Displaying 51-57 of 57 result(s).
ZONX Zonzia Media, Inc.
07/15/2016 9:14:18 AM
ZONX $$ Bullish Breakout Buying in
UNDERVALUED PENNY STOCKS
04/03/2016 3:38:46 PM
NWTR $3.50 Target New Wall Street P
NWTR New Western Energy Corp
04/03/2016 3:31:14 PM
New Western Energy NWTR $3.50 New T
UNDERVALUED PENNY STOCKS
03/21/2016 2:47:03 PM
$ NWTR $ 3.75-5.50 Wall Street Targ
UNDERVALUED PENNY STOCKS
03/19/2016 4:05:31 PM
$ NWTR$ Billionaire Investors wise
UNDERVALUED PENNY STOCKS
03/17/2016 8:50:47 AM
$ NWTR $$ Target Price 3.75-5.50$ p
NWTR New Western Energy Corp
03/15/2016 8:53:28 AM
$$ NWTR $$ target price $3.75-5.50$
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Vaultro Finance Hits Major Presale Milestone on XRP Ledger
  • Semaglutide’s Potential: A Breakthrough for Diabetic Care
  • Canadian North Resources Reports Positive Shareholder Meeting Outcomes
  • Teamsters Nurses Unite for Fair Treatment in Contract Talks
  • Explore Radcred's Streamlined Debt Consolidation Loan Options
  • Acki Nacki Teams Up with Renowned Casters for Exciting Games
  • Recap of the 27th Shanghai International Film Festival Awards
  • Kaanch Network's Bold Steps Towards Transforming DeFi in 2025
  • Wilson Blanchard Management's Successful WB CondoCon Event
  • Martini Market $MRT Presale Hits 40% Milestone Within a Day
  • Lawsuit Filed by Attorneys Against Universal Health Services
  • Vaultro Finance Sees Surge in $VLT Presale on XRP Ledger
  • Long Read Sequencing Market Anticipated to Surge to Nearly $7 Billion
  • Discover How QuidMiner Revolutionizes Cloud Mining Today
  • AIXA Miner Launches Innovative Free Cloud Mining Platform
  • Perspective Therapeutics Advances Clinical Trial for Cancer Treatment
  • Significant Efficacy of Vyepti in Treating Severe Migraines
  • Eptinezumab's Impact on Severe Migraines: New Insights
  • MetaVia Unveils Promising DA-1241 Data for Liver Health
  • Eli Lilly's Orforglipron Shows Promise for Type 2 Diabetes
  • Eptinezumab's Trial Results: A Breakthrough in Migraine Treatment
  • Investors Can Step Forward in Vestis Corporation Legal Challenge
  • New Insights on Eptinezumab's Effectiveness for Chronic Migraines
  • Perspective Therapeutics Showcases Innovations in Cancer Treatment
  • Shokz Introduces 5 Pro Athletes for Upcoming Endurance Run
  • Bitcoin Solaris Prepares for Exciting Public Launch Next Month
  • William Stern's Cardiff Transforms Working Capital Solutions
  • MolecuLight Unveils Multimodal Imaging Innovations for Wound Care
  • Innovative Diabetes Treatments Unveiled by Gan & Lee Pharmaceuticals
  • AIXA Miner: Revolutionizing Passive Income in Crypto Space
  • Teamsters Nurses Gear Up for Rally Ahead of Negotiations
  • Class Action Lawsuit Opportunity for Compass Diversified Holdings Investors
  • High Arctic Energy Services Reports Successful Annual Meeting
  • Key Updates on Reckitt Benckiser Securities Class Action
  • Understanding the Red Cat Holdings Class Action Lawsuit
  • Legal Update: Compass Diversified Shareholder Lawsuit News
  • Investor Alert: Key Information for Organon Shareholders
  • Investors in Tempus AI - Know Your Rights and Options
  • The China Fund, Inc. Moves Forward with Liquidation Plan
  • DDB Worldwide Achieves Unmatched Recognition at Cannes Lions
  • CHAI Transforms AI Performance with Innovative 4-Bit Model
  • Join the Movement: Apple Class Action Lawsuit Opportunities
  • Enzon and Viskase Announce Exciting Merger Agreement Plans
  • Jane Silverstone Segal's Significant Share Acquisition in DAVIDsTEA
  • enCore Energy Sells Shares to Strengthen Market Position
  • Revolutionize Your Finances with the New XRP Mining App
  • Novo Nordisk Reveals Exciting Amycretin Data at ADA 2025
  • Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough
  • Innovative Stem Cell Therapies Offer Hope for Diabetes Care
  • Breakthrough Study: Abbott's Program Enhances Diabetes Care
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site